Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
株式のランク #18727
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
株価
$2.35
時価総額
$4.22M
変化(1日)
-5.69%
変化(1年)
838.98%
MY
取引 BioNexus Gene Lab Corporation (BGLC)

カテゴリー

BioNexus Gene Lab Corporation(BGLC)のP/B比率
March 2026 時点のP/B比率 TTM: 0.59
BioNexus Gene Lab Corporation の最新の財務報告および株価によると、現在のP/B比率(TTM)は 0.59 です。2023 年末時点でのP/B比率は 0.95 でした。
BioNexus Gene Lab Corporation の P/B 比率の履歴(2016 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
2026 (TTM) 0.59 -1.60%
2024 0.60 -36.56%
2023 0.95 -96.17%
2022 24.65 -51.50%
2021 50.81 49.46%
2020 34.00 -79.93%
2019 169.36 76.55%
2018 95.93 -94.47%
2017 1.74K -101.39%
2016 -125.28K 0.00%
同業他社のP/B比率
企業 P/B比率 P/B比率の差
3.2693 453.74%
US
2.522 327.17%
US
28.6291 4,749.10%
US
3.6303 514.89%
CN
4.5682 673.75%
US